Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 2 |
2018 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV.
Sci Rep. 2023 Mar 23;13(1):4749. doi: 10.1038/s41598-023-29739-x.
Sci Rep. 2023.
PMID: 36959289
Free PMC article.
The impact of changes in HIV management guidelines on time to treatment initiation in Australia.
Puhr R, Petoumenos K, Youds D, Law MG, Templeton DJ; Australian HIV Observational Database (AHOD) study group.
Puhr R, et al.
HIV Med. 2017 Oct;18(9):701-703. doi: 10.1111/hiv.12504. Epub 2017 Feb 22.
HIV Med. 2017.
PMID: 28224755
Free PMC article.
No abstract available.
Item in Clipboard
Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study.
Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Madero JS, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Alberto Arnaiz J, Cooper D, Rockstroh JK, Mallon P, Emery S; MARCH study group.
Pett SL, et al.
HIV Med. 2018 Jan;19(1):65-71. doi: 10.1111/hiv.12532. Epub 2017 Jul 13.
HIV Med. 2018.
PMID: 28703491
Free article.
Clinical Trial.
Item in Clipboard
Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study.
Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Sierra Madero J, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Fisher M, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Arnaiz JA, Cooper D, Rockstroh JK, Mallon P, Emery S; Maraviroc Switch (MARCH) Study Group.
Pett SL, et al.
Clin Infect Dis. 2016 Jul 1;63(1):122-32. doi: 10.1093/cid/ciw207. Epub 2016 Apr 5.
Clin Infect Dis. 2016.
PMID: 27048747
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite